HHS

'The Clock Is Ticking' For Cannabis Rescheduling, Says Former Congressman Ed Perlmutter
The Medical Cannabis Explosion Just Got Real
GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own
The Medical Cannabis Explosion Just Got Real
GOP Sen. John Cornyn Takes Health Secretary To Task Over Cannabis Rescheduling: Xavier Becerra Holds His Own
Congressman Presses DEA For Action On Cannabis Scheduling Review, Calls Current Situation 'Arcane And Out-Of-Touch'
Biden's Reelection Hopes Boosted By Youth Support For Weed Reform

HHS Recent News

Feds Finally Release Documents Confirming Recommendation To Reschedule Cannabis Based On 'Accepted Medical Use'
The U.S.
Congressman Presses DEA On Marijuana Rescheduling Review: 'Move As Swiftly As Possible'
U.S. Rep Steve Cohen (D-TN) has fired a shot across the bow of the Drug Enforcement Administration (DEA), demanding swift action on the ongoing review of marijuana's federal classification.
DEA To Congress: We Hold 'Final Authority' On Cannabis Rescheduling, Overruling Biden's Health Authorities
The Drug Enforcement Administration (DEA) told House lawmakers that the agency is “now conducting its review” of marijuana as a Schedule 1 drug, according to a letter obtained by Punchbowl News.
Federal Agency Finally Releases Info On Cannabis Rescheduling Suggestions To DEA, Most Important Data Redacted
The Health and Human Services Department (HHS) released more details regarding its recommendation to the DEA to reclassify cannabis to Schedule III under the federal Controlled Substances Act (CSA).
How Does Cannabis Reclassification To Schedule III Differ From De-Scheduling & What Is Ideal Reform? Legal Expert Explains
Over the past several years, the US cannabis industry has experienced many important milestones.
Cross-Political Coalition To Biden: Deschedule Cannabis, Don't Just Rebrand Federal Criminalization
In an unprecedented show of unity, diverse advocacy groups come together to lobby President Biden for full marijuana legalization in 2023.
Marijuana Legalization: 31 Bipartisan House Reps Urge DEA To Reassess Cannabis Scheduling
A coalition of 31 bipartisan House members sent a letter to DEA administrator Anne Milgram, urging the agency to consider congressional and state marijuana legalization efforts as it carries out its review into
Why Did The Deptartment Of Health And Human Services Redact Its Marijuana Recommendation Letter To The DEA?
Ultimately the DEA has the final word on changing cannabis' draconion classification as a dangerous drug like heroin.
DEA Vs. HHS Over Marijuana Rescheduling: Former Gov Officials Say It Would 'Supersize' The Industry
Former DEA chiefs and retired White House drug czars are expressing concerns over the possible rescheduling of cannabis.
Congress To Discuss Kratom Products Regulation, Introduce Bipartisan Consumer Protection Act
Congressional lawmakers from both sides of the aisle introduced a bicameral bill calling for further federal evaluation of kratom’s health and safety and prohibiting the Dept of Health and Human Services (HHS) from imposing more restrictive requirements on it than those for food or dietary supplements as a way of creating national regulations.</
Attorney Sues HHS For Copy Of Biden's Letter Requesting Cannabis Scheduling Review, Does It Exist?
Attorney Matthew C. Zorn filed a complaint Friday in the U.S. District Court in Washington, D.C. against the Dept of Health and Human Services (HHS) demanding that it produce a requested copy of the letter issuing the cannabis scheduling review directive.
Republicans Present Bill Blocking Cannabis Legalization Without Congressional Approval
Senator Cynthia Lummis (R) and her colleague Senator Steve Daines (R), presented a bill to block cannabis legalization without congressional approval.
Marijuana Should Be Reclassified To Reflect Its Medical Potential, Says American Council Of Cannabis Medicine
The American Council of Cannabis Medicine (ACCM) supports the Health and Human Services (HHS) recommendation to reclassify cannabis from a Schedule I to a Schedule III controlled substance.
Tilray CEO Bullish On Beer And Cannabis Legalization, Moves Closer To $4B 'Aspirational Goal'
Tilray Brands (NASDAQ: TLRY) chairman and CEO Irwin D. Simon says his company is set to capitalize on possible cannabis legalization in the U.S. and anticipates creating beer infused with cannabis if/when it becomes legal.
DEA Doubles Down On Firing Of Special Agent Who Legally Used Hemp-Derived CBD Oil
The case around the DEA's decision to terminate the employment of a special agent in 2020 after testing positive for THC is heating up, reported Marijuana Moment’s Kyle Jaeger.
One Step Forward On The Road To Federal Cannabis Reform
Leafly's Take: Cannabis Reclassification, Consumer Choices And The Budtender Connection
In an exclusive interview with Benzinga, Carlos Pinto, chief commercial officer (CCO) of Leafly Holdings Inc. (NASDAQ: LFLY) discussed the strategic shift the cannabis marketplace and education platform has undergone.
Report: 650% Spike In Cannabis Medicine Trials Prioritizing Chronic And Neuropathic Pain
Could the future of healthcare be intertwined with cannabis-based medicines?
How Much Cannabis Does America Really Grow And How It Compares To Other Big Crops: Answer Might Surprise You
Leafly Holdings, Inc. (NASDAQ: LFLY) annual Cannabis Harvest Report reveals that in some states, cannabis is consistently one of the highest-value crops in the field, though the federal government and some state and local governments do not track weed ha
Chuck Schumer Pushes For Cannabis Banking In His Weekly 'Dear Colleague' Letter
In his weekly Dear Colleague letter, Senate Majority Leader Chuck Schumer (D-NY) renewed his call to pass a cannabis banking bill before the legislative period runs out.
August's Top-Performing ETF Is Marijuana-Related: Relaxed Federal Cannabis Laws Coming?
The AdvisorShares Pure US Cannabis ETF (NASDAQ: MSOS) surged by more than 14% on Thursday as the whole cannabis sector experienced a boost of enthusiasm on news that the Department of Health and Human Services was officially 
Cannabis Tax Changes Could Trigger 504% Cash Flow Leap, Which Industry Players Will Benefit?
The Department of Health and Human Services' recommendation to reclassify marijuana as a Schedule III drug under the
Health Dept Decision To Move Cannabis To Lower-Risk Category: Bull Case Narrative For The Industry
Recent news that the Department of Health and Human Services (HHS) is recommending the reclassification of marijuana as a Schedule III drug under the Controlled Substances Act has

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved